Ser396
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.8.0
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser396  -  ARHGEF14 (human)

Site Information
AMBIGUOUS SITES: A2ML1 (human): , ASCC3 (human): , ATM (human): , DOCK9 (human): , ETB (human): , ETEA (human): , LZTS1 (human): , MDH2 (human): , NRD1 (human): , RYR1 (human): , RYR2 (human): , RYR3 (human): , SCP2 (human): , TPD52 (human):
HLLRDLAsFEEKSGV   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 50323169

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 )
Disease tissue studied:
breast cancer ( 1 )
Relevant cell line - cell type - tissue:

References 

1

Imami K, et al. (2012) Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways. Mol Cell Proteomics 11, 1741-57
22964224   Curated Info